Pfizer amps up push into obesity treatments with $4.9B deal with Metasera
admin 5 hours agoUSA UpdateComments Off on Pfizer amps up push into obesity treatments with $4.9B deal with Metasera0 Views
Five months after ending development of its own obesity treatment, Pfizer is accelerating its push into the rapidly growing field with a nearly $5 billion acquisition.
